Adenovirus-mediated gene transfer in canine eyes: A preclinical study for gene therapy of human uveal melanoma

Journal of Gene Medicine

Volumn 3, Issue 3, 2001, Pages 228-239

  Andrawiss, Mariam ^a,c   Maron, Anne ^a   Beltran, William ^b   Opolon, Paule ^a   Connault, Elizabeth ^a   Griscelli, Frank ^a   Yeh, Patrice ^a   Perricaudet, Michel ^a   Devauchelle, Patrick ^b  

^a UMR 2582 CNRS IGR Aventis Gencell   (France)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adenovirus; Angiostatin; Dog eye; Gene therapy; Reporter gene; Uveal melanoma

Indexed keywords

ADENOVIRIDAE; CANIS FAMILIARIS;

ANGIOSTATIN; PEPTIDE FRAGMENT; PLASMINOGEN;

ADENOVIRUS; ANIMAL; ANTERIOR EYE CHAMBER; ANTIBODY PRODUCTION; AQUEOUS HUMOR; ARTICLE; DISEASE MODEL; DOG; FEASIBILITY STUDY; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; PATHOLOGY; UVEA TUMOR; VIROLOGY;

ADENOVIRIDAE; ANGIOSTATINS; ANIMALS; ANTERIOR CHAMBER; ANTIBODY FORMATION; AQUEOUS HUMOR; DISEASE MODELS, ANIMAL; DOGS; FEASIBILITY STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; PEPTIDE FRAGMENTS; PLASMINOGEN; UVEAL NEOPLASMS;

EID: 0035346066     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-2254(200105/06)3:3<228::AID-JGM186>3.0.CO;2-A     Document Type: Article

References (46)

1. Egan KM, Seddon JM, Glynn RJ, Gradoudas ES, Albert DM. Epidemiological aspects of uveal melanoma. Surv Ophthalmol 1988; 32: 239-251.
2. Gamel JW, McLean IW, McCurdy JB. Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma. Cancer 1993; 71: 2299-2305.
3. Donoso LA, Berd D, Augsburger JJ, Mastrangelo MJ, Shields JA. Metastatic uveal melanoma. Pretherapy serum liver enzyme and liver scan abnormalities. Arch Ophthalmol 1985; 103: 796-798.
4. Albert DM, Niffenegger TS, Willson JK. Treatment of metastatic melanoma: review and recommandations. Surv Ophthalmol 1992; 36: 429-438.
5. Richardson PSR, Cooke K, Gerrish P, Rees RC, Rennie IG. Natural killer and lymphokine-activated cytotoxicity following anaesthesia in patients with uveal malignant melanoma. Melanoma Res 1997; 7: 129-137.
6. Zimmermann LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells? Br J Ophthalmol 1978; 62: 420-425.
7. Mashhour B, Couton D, Perricaudet M, Briand P. In vivo adenovirus-mediated gene transfer into ocular tissues. Gene Ther 1994; 1: 122-126.
8. Jomary C, Piper TA, Dickson G, et al. Adenovirus-mediated gene transfer to murine retinal cells in vitro and in vivo. FEBS Lett 1994; 347: 117-122.
9. Li T, Adamian M, Roof DJ, et al. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest Ophthalmol 1994; 35: 2543-2549.
10. Budenz DL, Bennett J, Alonso L, Maguire A. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest Ophthalmol Vis Sci 1995; 36: 2211-2215.
11. Benett J, Pakola S, Zeng Y, Maguire A. Humoral response after administration of E1-deleted adenoviruses: immune privilege of the subretinal space. Hum Gene Ther 1996; 7: 1763-1769.
12. Schurmans LR, den Boer AT, Diehl L, et al. Successful immunotherapy of an intraocular tumor in mice. Cancer Res 1999; 59: 5250-5254.
13. Malecaze F, Couderc B, de Neuville S, et al. Adenovirus-mediated suicide gene transduction: feasibility in lens epithelium and in prevention of posterior capsule opacification in rabbit. Hum Gene Ther 1999; 10: 2365-2372.
14. Borras T, Rowlette LL, Erzurum SC, Epstein DL. Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma. Gene Ther 1999; 6: 515-524.
15. Yu MJ, Shen WY, Lai MC, Constable LJ, Rakoczy PE. Generation and characterization of a recombinant adenovirus expressing vascular endothelial growth factor for studies of neovascularization in the eye. Aust N Z J Ophthalmol 1999; 27: 250-253.
16. Lai CM, Shen WY, Constable I, Rakoczy PE. The use of adenovirus-mediated gene transfer to develop a rat model for photoreceptor degeneration. Invest Ophthalmol 2000; 41: 580-584.
17. Ma D, Gerard RD, Li XY, Alizadeh H, Niederkorn JY. Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model. Blood 1997; 90: 2738-2746.
18. Hurwitz MY, Marcus KT, Chevez-Barrios P, Louie K, Aguilar-Cordova E, Hurwitz RL. Suicide gene therapy for treatment of retinoblastoma in a murine model. Hum Gene Ther 1999; 10: 441-448.
19. Dubielzig RR, Aguirre GD, Gross SL, Diters RW. Choroidal melanomas in dogs. Vet Pathol 1985; 22: 582-585.
20. Bostock DE. Prognosis after surgical excision of canine melanomas. Vet Pathol 1979; 16: 32-40.
21. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 1992; 70: 291-301.
22. Bussanich NM, Dolman PJ, Rootman J, et al. Canine uveal melanomas: series and literature review. J Am Anim Hosp Assoc 1987; 23: 415-422.
23. Ryan AM, Diters RW. Clinical and pathologic features of canine ocular melanomas. JAVMA 1984; 184: 60-67.
24. Trucksa RC, McLean IW, Quinn AJ. Intraocular melanocytic neoplasms. J Am Anim Hosp Assoc 1985; 21: 85-88.
25. Wilcock BP, Peiffer RL. Morphology and behavior of primary ocular melanomas in 91 dogs. Vet Pathol 1986; 23: 418-424.
26. O'Reilly M, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumours in mice. Nat Med 1996; 2: 689-692.
27. Griscelli F, Li H, Bennaceur-Griscelli A, et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci U S A 1998; 95: 6367-6372.
28. Stratford-Perricaudet LD, Levrero M, Chasse JF, Perricaudet M, Briand P. Evaluation of the transfer and expression in mice of an enzyme encoding gene using a human adenovirus vector. Hum Gene Ther 1990; 1: 241-256.
29. Crouzet J, Naudin L, Orsini C, et al. Recombinational construction in Escherichia coli of infectious adenoviral genomes. Proc Natl Acad Sci U S A 1997; 94: 1414-1419.
30. Fallaux F, Bout A, van der Velde I, et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 1998; 9: 1909-1917.
31. Graham FL, Smiley J, Russel WC, Nairu R. Characteristics of a human cell line transformed by the DNA from human adenovirus 5. J Gen Virol 1977; 36: 59-72.
32. Graham S, Haughey B, Marshall J, et al. Diet in the epidemiology of carcinoma in the prostate gland. J Natl Cancer Inst 1983; 70: 687-692.
33. Yeh P, Dedieu JF, Orsini C, Vigne E, Denefle P, Perricaudet P. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol 1996; 70: 559-565.
34. Dedieu JF, Vigne E, Torrent C, et al. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J Virol 1997; 71: 4626-4637.
35. Hierholzer JC, Halonen PE, Dahlen PO, Bingham PG, McDonough MM. Detection of adenovirus in clinical specimens by polymerase chain reaction and liquid-phase hybridization quantitated by time-resolved fluorometry. J Clin Microbiol 1993; 31: 1886-1891.
36. Tursz T, Le Cesne E, Baldeyrou P, et al. Phase I of a recombinant adenovirus-mediated gene transfer in lung cancer patients. J Natl Cancer Inst 1996; 88: 1857-1863.
37. Andrawiss M, Opolon P, Benihoud K, et al. Adenovirus-mediated gene transfer in dog prostate: a relevant model system for gene therapy of human prostatic cancer. Prostate Cancer Prostat Dis 1999; 2: 25-35.
38. Thimmappaya B, Weinberger C, Schneider RJ, Shenk T. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late time after infection. Cell 1982; 31: 543-551.
39. Hayes ML, Castellino FJ. Carbohydrate of the human plasminogen variants. II. Structure of the asparagine-linked oligosaccharide unit. J Biol Chem 1979; 254: 8772-8776.
40. Lee Sim BK, O'Reilly MS, Liang H, et al. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 1997; 57: 1329-1334.
41. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol 1990; 48: 191.
42. Vinores SA, Kuchle M, Mahlow J, Chiu C, Green WR, Campochiaro PA. Blood-ocular barrier breakdown in eyes with ocular melanoma. Am J Pathol 1995; 147: 1289-1297.
43. Reichel MB, Ali RR, Trasher AJ, Hunt DM, Bhattacharya SS, Baker D. Immune response limit adenovirally mediated gene expression in the adult mouse eye. Gene Ther 1998; 5: 1038-1046.
44. Ali RR, Reichel MB, Byrnes AP, et al. Co-injection of adenovirus expressing CTLA4-Ig prolongs adenovirally mediated IacZ reporter gene expression in the mouse retina. Gene Ther 1998; 5: 1561-1565.
45. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
46. O'Reilly MS. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328.